Saturday - April 11, 2026

EveryCat Health Foundation Funding of Feline Health Science Lays Groundwork for Vital Translational Healthcare Breakthroughs in COVID, Cancer Treatment

EveryCat Health Foundation’s research support sets the stage for today’s feline to human translational healthcare discoveries WYCKOFF, N.J – For decades, EveryCat Health Foundation, a non-profit dedicated to advancing feline health by supporting a variety of research and education initiatives, … Continue reading

Multiple System Atrophy Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Neuramedy, ProMIS Neurosciences, Enterin Inc., Nippon Chemiphar

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple System Atrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Multiple System Atrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading

TECHSPO Dubai 2026 Unites Business, Tech and Marketing Leaders for High-Impact Expo

Dubai, UAE – TECHSPO Dubai Technology Expo returns September 22-23, 2026, to the Sofitel Dubai Jumeirah Beach Hotel, uniting business leaders, technologists, marketers, and innovators for a high-impact, two-day showcase of next-generation digital technology. Part of the globally recognized TECHSPO … Continue reading

DigiMarCon Silicon Valley 2026 Returns to San Francisco, Bringing the Future of Digital Marketing to the Global Stage

San Francisco, CA – DigiMarCon Silicon Valley, the premier digital marketing, media, advertising, and business conference and exhibition in the CA, will return June 16-17, 2026, at the Grand Hyatt San Francisco Hotel in San Francisco, CA. The three-day event … Continue reading

Non Tuberculous Mycobacterial Infections Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Insmed, AN2 Therapeutics, Mannkind Corp., Spero Therapeutics, Savara Pharmaceuticals

The Key Non- Tuberculous Mycobacterial Infections Companies in the market include – Insmed, AN2 Therapeutics, Mannkind Corporation, Spero Therapeutics, Savara Pharmaceuticals, Mallinckrodt Inc., Paratek Pharmaceuticals Inc., Revimmune, and others .   The Non- Tuberculous Mycobacterial Infections market is expected to … Continue reading